/PRNewswire/ Pioneering scientist and business leader Dr Chris Senanayake PhD has won two 2022 Business Worldwide Magazine CEO Awards. The CEO and founder.
Share this article
Share this article
ROCKVILLE, Md., May 20, 2021 /PRNewswire/ Shuttle Pharmaceuticals Holdings, Inc., (Shuttle Pharma) a clinical stage company developing drugs to improve the treatment of cancer patients undergoing radiation therapy is pleased to announce the addition of Chris Senanayake, PhD as a member of its Board of Directors. Shuttle Pharma believes Dr. Senanayake is uniquely qualified to serve as a board member because of his vast experience and expertise in the pharmaceuticals industries.
Dr. Senanayake has more than 30 years of pharmaceutical industry experience, making him an invaluable asset to Shuttle Pharma s mission as the Company advances its pharmaceutical candidates in clinical trials. He is the Founder and Chief Executive Officer (CEO) of TCG GreenChem Inc. and Chief Scientific Officer of TCG Lifesciences, Pvt. Ltd. He has held positions of Senior Scientist at Dow Chemical, Research Fellow at Merck & Co, Inc. Director and Executive Director o